News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,903 Results
Type
Article (13969)
Company Profile (102)
Press Release (254832)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (88332)
Career Advice (465)
Deals (15391)
Drug Delivery (67)
Drug Development (36928)
Employer Resources (49)
FDA (6331)
Job Trends (6224)
News (150852)
Policy (14125)
Tag
Academia (468)
Accelerated approval (3)
Adcomms (6)
Allergies (42)
Alliances (23353)
ALS (41)
Alzheimer's disease (406)
Antibody-drug conjugate (ADC) (54)
Approvals (6381)
Artificial intelligence (132)
Autoimmune disease (9)
Automation (5)
Bankruptcy (150)
Best Places to Work (4384)
BIOSECURE Act (9)
Biosimilars (59)
Biotechnology (40)
Bladder cancer (23)
Brain cancer (18)
Breast cancer (104)
Cancer (793)
Cardiovascular disease (81)
Career advice (409)
Career pathing (12)
CAR-T (27)
CDC (3)
Cell therapy (97)
Cervical cancer (5)
Clinical research (31316)
Collaboration (412)
Compensation (186)
Complete response letters (17)
COVID-19 (849)
CRISPR (28)
C-suite (159)
Cystic fibrosis (43)
Data (879)
Denatured (16)
Depression (13)
Diabetes (89)
Diagnostics (1354)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (68)
Drug pricing (78)
Drug shortages (12)
Duchenne muscular dystrophy (47)
Earnings (32648)
Editorial (14)
Employer branding (4)
Employer resources (44)
Events (38134)
Executive appointments (457)
FDA (6890)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (265)
Gene editing (46)
Generative AI (9)
Gene therapy (112)
GLP-1 (373)
Government (1342)
Grass and pollen (3)
Guidances (77)
Healthcare (3670)
Huntington's disease (5)
IgA nephropathy (16)
Immunology and inflammation (40)
Immuno-oncology (2)
Indications (18)
Infectious disease (885)
Inflammatory bowel disease (60)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (59)
Interviews (59)
IPO (5933)
IRA (31)
Job creations (2055)
Job search strategy (373)
Kidney cancer (7)
Labor market (17)
Layoffs (189)
Leadership (4)
Legal (3446)
Liver cancer (19)
Lung cancer (109)
Lymphoma (68)
Machine learning (4)
Management (16)
Manufacturing (194)
MASH (39)
Medical device (1314)
Medtech (1316)
Mergers & acquisitions (9710)
Metabolic disorders (296)
Multiple sclerosis (31)
NASH (14)
Neurodegenerative disease (31)
Neuropsychiatric disorders (10)
Neuroscience (633)
NextGen: Class of 2025 (1600)
Non-profit (606)
Now hiring (11)
Obesity (168)
Opinion (127)
Ovarian cancer (25)
Pain (65)
Pancreatic cancer (25)
Parkinson's disease (51)
Partnered (7)
Patents (143)
Patient recruitment (37)
Peanut (13)
People (29169)
Pharmaceutical (64)
Pharmacy benefit managers (13)
Phase I (8160)
Phase II (13278)
Phase III (11876)
Pipeline (632)
Policy (90)
Postmarket research (1401)
Preclinical (3317)
Press Release (25)
Prostate cancer (60)
Psychedelics (8)
Radiopharmaceuticals (124)
Rare diseases (193)
Real estate (2640)
Recruiting (17)
Regulatory (10280)
Reports (14)
Research institute (594)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (4)
RSV (9)
Schizophrenia (43)
Series A (48)
Series B (16)
Service/supplier (3)
Sickle cell disease (33)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (7)
Startups (1635)
State (2)
Stomach cancer (3)
Supply chain (35)
Tariffs (42)
The Weekly (32)
Vaccines (184)
Venture capital (16)
Weight loss (103)
Women's health (8)
Worklife (4)
Date
Today (9)
Last 7 days (164)
Last 30 days (844)
Last 365 days (11301)
2025 (5619)
2024 (12587)
2023 (14360)
2022 (19741)
2021 (20339)
2020 (19244)
2019 (14955)
2018 (11750)
2017 (13929)
2016 (13146)
2015 (15488)
2014 (12423)
2013 (10592)
2012 (11395)
2011 (11927)
2010 (10890)
Location
Africa (318)
Alabama (15)
Alaska (2)
Arizona (60)
Arkansas (3)
Asia (20421)
Australia (2644)
California (2096)
Canada (1043)
China (319)
Colorado (83)
Connecticut (87)
Delaware (75)
Europe (39980)
Florida (407)
Georgia (46)
Idaho (9)
Illinois (233)
India (16)
Indiana (156)
Iowa (1)
Japan (125)
Kansas (62)
Kentucky (16)
Louisiana (2)
Maine (2)
Maryland (304)
Massachusetts (1795)
Michigan (35)
Minnesota (109)
Mississippi (1)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (12)
New Hampshire (6)
New Jersey (909)
New Mexico (8)
New York (651)
North Carolina (445)
North Dakota (2)
Northern California (878)
Ohio (54)
Oklahoma (4)
Oregon (16)
Pennsylvania (509)
Puerto Rico (9)
Rhode Island (10)
South America (506)
South Carolina (5)
Southern California (876)
Tennessee (39)
Texas (279)
United States (8663)
Utah (43)
Virginia (97)
Washington D.C. (38)
Washington State (138)
West Virginia (1)
Wisconsin (21)
268,903 Results for "rxi pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology
INTASYL Compound RXI-231: a promising approach to treatment of hyperpigmentation
January 2, 2025
·
5 min read
Policy
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
Phio’s Compound RXI-185 is designed to slow progression of UV induced collagen breakdown
June 18, 2024
·
4 min read
Genetown
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Phio Pharmaceuticals Corp. announced that the United States Patent and Trademark Office has granted patent application 17/150,614 for two of its INTASYL Compounds, RXI-185 and RXI-231.
March 6, 2024
·
4 min read
Press Releases
Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in on-going clinical study
May 16, 2025
·
9 min read
Press Releases
Kiora Pharmaceuticals and Senju Pharmaceutical Partner on KIO-301 for the Treatment of Retinal Diseases in Asia
June 3, 2025
·
6 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Press Releases
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
May 29, 2025
·
1 min read
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 5, 2025
·
1 min read
Press Releases
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
June 12, 2025
·
10 min read
1 of 26,891
Next
